Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Europe Myelofibrosis Market Pipeline and Competitive Landscape Highlights 2010-2020 - Research and Markets

Research and Markets
Posted on: 24 Oct 16

Research and Markets has announced the addition of the "Europe Myelofibrosis Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.

Europe Myelofibrosis Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Myelofibrosis pipeline products, Myelofibrosis epidemiology, Myelofibrosis market valuations and forecast, Myelofibrosis products sales and competitive landscape.

This report is classified into nine sections - Myelofibrosis overview including etiology, pathophysiology, and diagnosis, Myelofibrosis treatment options, Myelofibrosis pipeline products, Myelofibrosis market analysis in Europe and by each country.

The market analysis comprises of Myelofibrosis epidemiology, key products marketed for Myelofibrosis, market valuations and forecast, products sales and market shares.

Research Scope:

  • Pipeline: Find out the products in clinical trials for the treatment of Myelofibrosis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Epidemiology: Find out the number of patients diagnosed (prevalence) with Myelofibrosis
  • Products: Identify key products marketed and prescribed for Myelofibrosis including trade name, molecule name, and company
  • Product Sales: Find out the sales revenues of Myelofibrosis products, both branded and generics
  • Market Valuations: Find out the market size for Myelofibrosis products in 2015 for the markets: Find out how the market advanced from 2010 and forecast to 2020
  • Products Market Share: Find out the market shares for key Myelofibrosis products

Key Topics Covered:

1 Disease Overview

2 Myelofibrosis Treatments

3 Myelofibrosis Pipeline

4 Europe Myelofibrosis Market Insights

5 Germany Myelofibrosis Market Insights

6 France Myelofibrosis Market Insights

7 Italy Myelofibrosis Market Insights

8 Spain Myelofibrosis Market Insights

9 UK Myelofibrosis Market Insights

For more information about this drug pipelines report visit

View source version on

Business Wire

Last updated on: 24/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.